Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze TGRP stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TGRP investment potential.

What is TGRP stock price today?

Get real-time TGRP stock price, historical data, and price charts on Financhill. Track TGRP performance with our advanced analysis tools.

Is TGRP a good investment?

Evaluate TGRP investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TGRP stock?

To buy TGRP stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TGRP?

View detailed market capitalization data and company valuation metrics for TGRP on our comprehensive analysis page.

What is the P/E ratio of TGRP?

Use our fundamental analysis tools to view TGRP P/E ratio and compare valuation metrics with industry peers.

What are TGRP earnings?

View TGRP earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

TRON Pharmaceuticals, Inc. 10K Form

Buy

TGRP
TRON Pharmaceuticals, Inc.

Last Price:

$0.0498

Seasonality Move:

16.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2018-11-14	10Q	TGRP/TRON Pharmaceuticals, Inc. Quarterly
2018-08-20	10Q	TGRP/TRON Pharmaceuticals, Inc. Quarterly
2018-05-16	10Q	TGRP/TRON Pharmaceuticals, Inc. Quarterly
2018-04-11	10K	TGRP/TRON Pharmaceuticals, Inc. Annual
2017-11-07	10Q	TGRP/TRON Pharmaceuticals, Inc. Quarterly
2017-08-07	10Q	TGRP/TRON Pharmaceuticals, Inc. Quarterly

Receive TGRP News And Ratings

See the #1 stock for the next 7 days that we like better than TGRP

TGRP Financial Statistics

Sales & Book Value

Annual Sales:	$3.8M
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$0.00
Price / Book:	188.37

Profitability

Net Income (TTM):	$0
Gross Margin:	$1M
Return on Equity:	0%
Return on Assets:	0%

TRON Pharmaceuticals, Inc. Earnings Forecast

Key TRON Pharmaceuticals, Inc. Financial Ratios

The Gross Profit Margin over the past 7 years for TGRP is 26.26%.
The Selling, General & Administrative Expenses for TGRP have been equal to 28.91% of Gross Profit Margin.
The Research & Development expenses have been 2.23% of Revenue.
The Net Earning history of TGRP is -8.64% of Total Revenues.
Per Share Earnings over the last 7 years have been positive in 4 years.

TRON Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Current Symbol:	TGRP

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	0
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

TGRP Technical Analysis vs Fundamental Analysis

Buy

TRON Pharmaceuticals, Inc. (TGRP) is a Buy

Is TRON Pharmaceuticals, Inc. a Buy or a Sell?

TRON Pharmaceuticals, Inc. stock is rated a Buy

The current TRON Pharmaceuticals, Inc. [TGRP] share price is $0.0498. The Score for TGRP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.